Affluent Medical Sas Stock Beta

AFME Stock   1.66  0.01  0.60%   
Affluent Medical SAS fundamentals help investors to digest information that contributes to Affluent Medical's financial success or failures. It also enables traders to predict the movement of Affluent Stock. The fundamental analysis module provides a way to measure Affluent Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Affluent Medical stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Affluent Medical SAS Company Beta Analysis

Affluent Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Affluent Medical SAS has a Beta of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The beta for all France stocks is 100.0% lower than that of the firm.

Affluent Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Affluent Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Affluent Medical could also be used in its relative valuation, which is a method of valuing Affluent Medical by comparing valuation metrics of similar companies.
Affluent Medical is currently under evaluation in beta category among its peers.

Affluent Fundamentals

About Affluent Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Affluent Medical SAS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affluent Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affluent Medical SAS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Affluent Stock

Affluent Medical financial ratios help investors to determine whether Affluent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Affluent with respect to the benefits of owning Affluent Medical security.